Company Name, Ticker, Industry, else..

Bluejay Diagnostics Inc (NASDAQ: BJDX)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Bluejay Diagnostics Inc's

Name: Bluejay Diagnostics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BJDX Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Bluejay Diagnostics Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, slower than the combined decrease of the BJDX's competitors by -1.46 %, recorded in the same quarter.

• List of BJDX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Bluejay Diagnostics Inc, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 35.97 %

<< BJDX Stock Performance Comparisons

<< See the full list of BJDX competitors

*Market share is calculated based on total revenue.

News about Bluejay Diagnostics Inc Contracts

Elevated IL-6 Levels Predict 28-Day Mortality in Sepsis Patients Insights from the SYMON-I Pilot Study

June 26, 2024
Interpreting IL-6 as a Predictor of Mortality in Sepsis Patients: Insights from the SYMON-I Study Sepsis, a life-threatening condition resulting from the body s dysregulated response to infection, presents a significant challenge in critical care medicine due to its high mortality rates. Early and accurate identification of patients at highest risk of mortality is crucial for improving outcomes. In this context, the exploration of biomarkers for prognostication has gained increasing attention. The SYMON-I pilot clinical study was designed to evaluate the utility of Interleukin-6 (IL-6) as a prognostic biomarker for predicting mortality in sepsis patients admitted to intensive care units (ICUs). Study Overvi...

BJDX's Stock Performance relative to its Competitors

Publicly Traded Peers of Bluejay Diagnostics Inc

Allurion Technologies Inc
Share Performance

-21.38%

This Year

Allurion Technologies Inc

Profile

Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.

More about Allurion Technologies Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 15.220 mill.	$ 12.357 mill.	$ -42.229 mill.

Quidelortho Corp
Share Performance

-58.32%

One Year

Quidelortho Corp

Profile

Quidelortho Corp operates on a business model that focuses on manufacturing and selling orthodontic products. They leverage their expertise in the orthodontic industry to design and create quality products that cater to the needs of orthodontists and patients. Their revenue is generated through the sales of these products to orthodontic practices and distribution through strategic partnerships.

More about Quidelortho Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 852.384 mill.	$ 2,674.200 mill.	$ -1,048.400 mill.

Orasure Technologies Inc
Share Performance

-10.94%

Over The Past 5 Days

Orasure Technologies Inc

Profile

Orasure Technologies Inc's business model revolves around the development, manufacturing, and distribution of innovative diagnostic products, primarily in the field of oral fluid diagnostics.

More about Orasure Technologies Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 225.558 mill.	$ 111.978 mill.	$ -49.126 mill.

Milestone Scientific Inc
Share Performance

+8.32%

This Quarter

Milestone Scientific Inc

Profile

Milestone Scientific Inc's business model focuses on developing and commercializing innovative medical devices and instruments, particularly in the field of drug delivery. Their products strive to enhance patient comfort and improve clinical outcomes through precision and ease of use.

More about Milestone Scientific Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 38.331 mill.	$ 8.855 mill.	$ -4.144 mill.

Lucid Diagnostics Inc
Share Performance

-18.61%

Over The Past 5 Days

Lucid Diagnostics Inc

Profile

Lucid Diagnostics Inc is a healthcare company that operates with a business model focused on developing and providing innovative diagnostic solutions for the early detection and prevention of diseases, aimed at improving patient outcomes and reducing healthcare costs. They leverage advanced technologies and medical expertise to deliver accurate and reliable diagnostic services to healthcare providers, enabling better decision-making and personalized treatment plans for patients.

More about Lucid Diagnostics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 147.562 mill.	$ 5.445 mill.	$ -64.818 mill.

9 more competitors available

Sources: Bluejay Diagnostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 8:21 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bluejay Diagnostics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.